Viewing Study NCT01228760

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-06-30 @ 6:34 AM
Study NCT ID: NCT01228760
Status: COMPLETED
Last Update Posted: 2013-06-07
First Post: 2010-10-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Castration-Resistant Prostate Cancer View
None ASG-5ME View
None Pharmacokinetics of ASG-5ME View